FDA approves AI imaging device for breast cancer surgery
The device, known as Claire, has become the first AI-enabled system approved for real-time assessment of tumor margins during breast surgery.
News
-
-
Anxiety and depression prevalent in women with breast cancer
Women with breast cancer have a significantly higher risk of depression, anxiety and stress compared to those without it, a review showed.
-
Fear of cancer returning linked to persistent pain and fatigue
Fear of cancer returning may be associated with long-term pain and tiredness, even long after their treatment ends.
-
Enhertu granted FDA priority review for HER2-positive breast cancer
AstraZeneca and Daiichi Sankyo are seeking approval for Enhertu in people with residual disease after HER2-targeted therapy before surgery.
-
Inflammatory diet associated with higher breast cancer risk
A recent review showed that eating more inflammatory foods is significantly associated with increased breast cancer risk.
-
Minorities underrepresented in clinical trials for breast cancer
Researchers say improving inclusion will require coordinated changes in how studies are designed, explained and made accessible.
-
Hypertension management linked to better survival in metastatic breast cancer
Treating hypertension with polytherapy was tied to a 38% lower risk of death from any cause in women with metastatic breast cancer.
-
First patient dosed in clinical trial for HER2-positive breast cancer
Innovent Biologics has dosed the first patient in their Phase 3 HeriCare-Breast01 trial of IBI354 in HER2-positive breast cancer.
-
Alcohol consumption linked to increased breast cancer risk
A recent study showed alcohol consumption is associated with an increased risk of breast cancer and poorer overall survival outcomes.
-
Immunotherapy improves survival in some types of breast cancer
Immunotherapy can improve the chance of tumor disappearance before surgery and may extend survival in certain high-risk groups.